ClinicalTrials.Veeva

Menu

Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)

H

Hadassah Medical Center

Status

Unknown

Conditions

NSCLC

Treatments

Other: A biopsy sample

Study type

Observational

Funder types

Other

Identifiers

NCT02283021
CALCIUM-HMO-CTIL

Details and patient eligibility

About

Calcium is an extremely important ion used in our body for many processes. One of its tasks is to control gene expression. Cells intake calcium from their surroundings though special calcium channels located on the surface membranes of the cells.

The great many studies on such calcium channels were performed on excitable cells such as muscle, heart or neuronal cells, where the calcium ions are controlled by voltage. Surprisingly, not much is known about the identity of calcium subunits in non-excitable cells like epithelial cells (which compose most of the connective tissue in the body), liver cells, lung cells, immune system cells, etc.

Recently, the investigators have shown that calcium channels from muscles are, in fact, expressed in T cells of the immune system, where they are used for proliferation. The investigators postulated that probably other cell types, especially cancerous cell types, might be using these subunits similarly.

The aim of this study is to determine the identity and sequence of calcium subunits expressed in non-small cell Lung Carcinoma (NSCLC), which accounts for 80% of the worldwide lung cancer deaths.

Full description

Initial examination of NSCLC cell lines determined that they express the mRNA of voltage gated calcium subunits, found normally in neurons. Furthermore sequence analysis of these subunits has shown that modifications have occurred.

The aim of the study in NSCLC patients is to sequence and clone the calcium channel subunits expressed in their tumor. Expression and Sequence will be compared between the normal and cancerous lung tissue for each patient.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • NSCLC patients
  • Patients without NSCLC
  • Men or woman between 18-80 years of age

Exclusion criteria

  • Pregnant woman

Trial design

200 participants in 2 patient groups

NSCLC Patients
Description:
Sample biopsies from normal and cancerous lung tissue.
Treatment:
Other: A biopsy sample
Patients without NSCLC
Description:
Sample biopsies from normal lung tissue.Control group.
Treatment:
Other: A biopsy sample

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems